好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Baseline Depressive Symptoms as Predictive of Seizure Frequency Reduction among Epilepsy Patients with Partial-Onset Seizures: A Pooled Analysis of Phase III Clinical Trials of Adjunctive Treatment with Eslicarbazepine Acetate
Epilepsy/Clinical Neurophysiology (EEG)
(-)
193
Authors/Disclosures

PRESENTER 		No disclosure on file
Fulton Velez No disclosure on file
No disclosure on file
No disclosure on file
Joyce A. Cramer (Yale University School of Medicine) No disclosure on file
Alexandros C. Tselis, MD, PhD (WSU Sch of Med/Dept of Neur Health Ctr) No disclosure on file
Hailong Cheng No disclosure on file
Rui Sousa No disclosure on file
David E. Blum, MD Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.